Effect of Dapagliflozin Combined with Metformin on Fat and Muscle Mass in Overweight and Obese Patients with Type 2 Diabetes
-
Published:2023
Issue:02
Volume:13
Page:2461-2467
-
ISSN:2161-8712
-
Container-title:Advances in Clinical Medicine
-
language:
-
Short-container-title:ACM
Publisher
Hans Publishers
Subject
General Engineering
Reference29 articles.
1. 傅姣. 达格列净对肥胖型2型糖尿病患者血清趋化素、生长分化因子-15、肾功能及糖代谢的影响[J]. 中国乡村医药, 2020, 27(16): 11-12.
2. 刘晓冰, 曾洁纯. SGLT-2抑制剂治疗肥胖型2型糖尿病患者对临床疗效及血清Chemerin的改善作用[J]. 糖尿病新世界, 2020, 23(7): 39-40.
3. 纪立农, 郭立新, 郭晓蕙, 等. 钠-葡萄糖共转运蛋白2 (SGLT2)抑制剂临床合理应用中国专家建议[J]. 中国糖尿病杂志, 2016, 24(10): 865-870.
4. Sodium glucose co-transporter 2 (SGLT2) inhibitors: novel antidiabetic agents
5. Adverse effects and safety of SGLT-2 inhibitors